Patent · US Expired

Use of 2-amino-3,4-dihydroquinazolines for the production of a medicament for the treatment or prophylaxis of illnesses caused by ischemic conditions

US6331546A · kind A · utility

0Cited by

1References

13Claims

0Family size

Assignee

Aventis Pharma Deutschland GmbH · DE

Inventors

Andreas Weichert · Egelsbach, DE
Udo Albus · Florstadt, DE
Hans-Willi Jansen · Niedernhausen, DE

Key dates

Filing date	Oct 26, 2000
Grant date	Dec 18, 2001
Priority date	—
Expiry date	Oct 26, 2020

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P41/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods of using 2-amino-3,4-dihydroquinazolines of formula I, or a pharmaceutically tolerable salt thereof, for the treatment or prophylaxis of illnesses caused by ischemic conditions: ##STR1## wherein: R1, R2 and R3 have the meanings indicated in the specification and claims.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.